Yojana Test

Context:

• AstraZeneca, the company that makes the Covishield vaccine for Covid-19 pandemic, has admitted the inoculation has potential side effects. 
• The company's admission, presented in a legal document before the High Court of Justice in London, conveys that the Covid vaccine can in extremely rare cases induce Thrombosis with Thrombocytopenia Syndrome (TTS).

 

What is Covishield?

• The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxzevria in Europe is a viral vector vaccine.
• It is adenovirus vector vaccine, a chimpanzee adenovirus - ChAdOx1 - has been modified to enable it to carry the Covid-19 (SARS-CoV-2) spike protein injected into the muscles of humans.
•  It was manufactured and marketed in India in partnership with Punebased Serum Institute of India, and was widely used during the country’s fight against the deadly Covid-19 pandemic.
  • Over 1.7 billion doses of Covishield have been administered so far globally.
  • More than 175 crore doses of Covishield have been administered in India.

 

paragraph

It was manufactured and marketed in India in partnership with Punebased Serum Institute of India, and was widely used during the country’s fight against the deadly Covid-19 pandemic.	It was manufactured and marketed in India in partnership with Punebased Serum Institute of India, and was widely used during the country’s fight against the deadly Covid-19 pandemic.
It was manufactured and marketed in India in partnership with Punebased Serum Institute of India, and was widely used during the country’s fight against the deadly Covid-19 pandemic.

•  It was manufactured and marketed in India in partnership with Punebased Serum Institute of India, and was widely used during the country’s fight against the deadly Covid-19 pandemic.
  • Over 1.7 billion doses of Covishield have been administered so far globally.
  • More than 175 crore doses of Covishield have been administered in India.